Rain Oncology Inc. (NASDAQ:RAIN – Get Rating) – Research analysts at HC Wainwright raised their Q2 2023 earnings per share estimates for Rain Oncology in a research report issued to clients and investors on Tuesday, May 23rd. HC Wainwright analyst M. Kapoor now expects that the company will earn ($0.44) per share for the quarter, […]
Citigroup cut shares of Rain Oncology (NASDAQ:RAIN – Get Rating) from a buy rating to a neutral rating in a research note published on Tuesday, The Fly reports. Several other research firms have also commented on RAIN. EF Hutton Acquisition Co. I reissued a buy rating and set a $16.00 price target on shares of […]
Lifesci Capital cut shares of Rain Oncology (NASDAQ:RAIN – Get Rating) from an outperform rating to a market perform rating in a report issued on Monday morning, PriceTargets.com reports. Several other equities analysts have also commented on the company. EF Hutton Acquisition Co. I reaffirmed a buy rating and issued a $16.00 price target on […]
Oppenheimer lowered shares of Rain Oncology (NASDAQ:RAIN – Get Rating) from an outperform rating to a market perform rating in a research report report published on Monday, The Fly reports. A number of other equities research analysts also recently issued reports on the stock. Mizuho decreased their price target on shares of Rain Oncology from […]
Lifesci Capital downgraded shares of Rain Oncology (NASDAQ:RAIN – Get Rating) from an outperform rating to a market perform rating in a research report report published on Monday, PriceTargets.com reports. Several other research firms have also commented on RAIN. Piper Sandler lowered shares of Rain Oncology from an overweight rating to a neutral rating in […]